REMODULIN Trademark

Trademark Overview

On Thursday, November 30, 2000, a trademark application was filed for REMODULIN with the United States Patent and Trademark Office. The USPTO has given the REMODULIN trademark a serial number of 76173227. The federal status of this trademark filing is REGISTERED AND RENEWED as of Saturday, January 14, 2023. This trademark is owned by United Therapeutics Corporation. The REMODULIN trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparation used in the treatment of cardiovascular, pulmonary, and vascular diseases; A pharmaceutical preparation used in the treatment of cardiopulmonary and cardiovascular diseases
remodulin

General Information

Serial Number76173227
Word MarkREMODULIN
Filing DateThursday, November 30, 2000
Status800 - REGISTERED AND RENEWED
Status DateSaturday, January 14, 2023
Registration Number2618835
Registration DateTuesday, September 10, 2002
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, January 8, 2002

Trademark Statements

Goods and Servicespharmaceutical preparation used in the treatment of cardiovascular, pulmonary, and vascular diseases; A pharmaceutical preparation used in the treatment of cardiopulmonary and cardiovascular diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, December 11, 2000
Primary Code005
First Use Anywhere DateTuesday, May 21, 2002
First Use In Commerce DateTuesday, May 21, 2002

Trademark Owner History

Party NameUnited Therapeutics Corporation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSilver Spring, MD 20910
Party NameUnited Therapeutics Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSilver Spring, MD 20910
Party NameUnited Therapeutics Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSilver Spring, MD 20910

Trademark Events

Event DateEvent Description
Saturday, January 14, 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Saturday, January 14, 2023REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
Saturday, January 14, 2023REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Saturday, January 14, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, June 29, 2022TEAS SECTION 8 & 9 RECEIVED
Friday, September 10, 2021COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Wednesday, September 19, 2012NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Tuesday, September 18, 2012REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Tuesday, September 18, 2012REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Tuesday, September 18, 2012CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, September 6, 2012TEAS SECTION 8 & 9 RECEIVED
Saturday, September 13, 2008REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Thursday, September 4, 2008ASSIGNED TO PARALEGAL
Wednesday, August 27, 2008TEAS SECTION 8 & 15 RECEIVED
Tuesday, December 4, 2007CASE FILE IN TICRS
Tuesday, September 10, 2002REGISTERED-PRINCIPAL REGISTER
Monday, June 24, 2002ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, June 17, 2002ASSIGNED TO EXAMINER
Friday, June 14, 2002STATEMENT OF USE PROCESSING COMPLETE
Tuesday, June 4, 2002USE AMENDMENT FILED
Tuesday, April 2, 2002NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 8, 2002PUBLISHED FOR OPPOSITION
Wednesday, December 19, 2001NOTICE OF PUBLICATION
Tuesday, October 2, 2001APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, September 20, 2001EXAMINERS AMENDMENT MAILED
Friday, September 14, 2001LETTER OF SUSPENSION MAILED
Wednesday, May 9, 2001CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 1, 2001NON-FINAL ACTION MAILED
Monday, April 23, 2001ASSIGNED TO EXAMINER
Sunday, April 8, 2001ASSIGNED TO EXAMINER
Thursday, April 5, 2001ASSIGNED TO EXAMINER
Thursday, April 5, 2001ASSIGNED TO EXAMINER
Thursday, March 29, 2001ASSIGNED TO EXAMINER

Related Keywords

remodulin pharmaceutical diseases treatment cardiovascular preparation used cardiopulmonary vascular pulmonary